Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population based cohort study

Ruijie Zeng, Yuying Ma, Lijun Zhang, Dongling Luo, Rui Jiang, Huihuan Wu, Zewei Zhuo, Qi Yang, Jingwei Li, Felix W Leung, Chongyang Duan, Weihong Sha, Hao Chen
doi: https://doi.org/10.1101/2022.08.21.22279047

Article usage

Article usage: August 2022 to June 2025

AbstractFullPdf
Aug 20224732175
Sep 20221766822
Oct 20221326019
Nov 2022776229
Dec 2022381621
Jan 202335228
Feb 202323418
Mar 2023361350
Apr 202326722
May 202313713
Jun 20231347
Jul 20237710
Aug 2023211311
Sep 202321516
Oct 202316913
Nov 202320135
Dec 20232048
Jan 20241431130
Feb 2024421115
Mar 202451229
Apr 202438713
May 20241812237
Jun 2024672115
Jul 202445618
Aug 2024271120
Sep 202447214
Oct 202433714
Nov 202420817
Dec 202417419
Jan 2025481221
Feb 2025258821
Mar 20256011828
Apr 202538940
May 2025501649
Jun 2025918
Back to top
Posted January 09, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population based cohort study
Ruijie Zeng, Yuying Ma, Lijun Zhang, Dongling Luo, Rui Jiang, Huihuan Wu, Zewei Zhuo, Qi Yang, Jingwei Li, Felix W Leung, Chongyang Duan, Weihong Sha, Hao Chen
medRxiv 2022.08.21.22279047; doi: https://doi.org/10.1101/2022.08.21.22279047
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area